132 related articles for article (PubMed ID: 15466383)
21. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
[TBL] [Abstract][Full Text] [Related]
22. Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus.
Bian Y; Zhao S; Zhu S; Zeng J; Li T; Fu Y; Wang Y; Zheng X; Zhang L; Wang W; Yang B; Zhou Y; Allain JP; Li C
PLoS One; 2013; 8(7):e70214. PubMed ID: 23894620
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
24. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
Yang SH; Lee CG; Song MK; Sung YC
Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
[TBL] [Abstract][Full Text] [Related]
25. Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.
Bugli F; Graffeo R; Pescatori M; Paroni Sterbini F; Torelli R; Masucci L; Manzara S; Fadda G
New Microbiol; 2009 Oct; 32(4):341-9. PubMed ID: 20128440
[TBL] [Abstract][Full Text] [Related]
26. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
27. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
28. Subcellular localisation of NS3 in HCV-infected hepatocytes.
Errington W; Wardell AD; McDonald S; Goldin RD; McGarvey MJ
J Med Virol; 1999 Dec; 59(4):456-62. PubMed ID: 10534726
[TBL] [Abstract][Full Text] [Related]
29. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
30. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.
Pang PS; Jankowsky E; Planet PJ; Pyle AM
EMBO J; 2002 Mar; 21(5):1168-76. PubMed ID: 11867545
[TBL] [Abstract][Full Text] [Related]
31. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
[TBL] [Abstract][Full Text] [Related]
32. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
[TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolones inhibit HCV by targeting its helicase.
Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of the hepatitis C virus replication complex.
Quinkert D; Bartenschlager R; Lohmann V
J Virol; 2005 Nov; 79(21):13594-605. PubMed ID: 16227280
[TBL] [Abstract][Full Text] [Related]
35. Characterization of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) helicase activity and its modulation by CSFV RNA-dependent RNA polymerase.
Wen G; Xue J; Shen Y; Zhang C; Pan Z
Virus Res; 2009 Apr; 141(1):63-70. PubMed ID: 19185595
[TBL] [Abstract][Full Text] [Related]
36. Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein.
Sullivan DE; Mondelli MU; Curiel DT; Krasnykh V; Mikheeva G; Gaglio P; Morris CB; Dash S; Gerber MA
J Hepatol; 2002 Nov; 37(5):660-8. PubMed ID: 12399234
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
38. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein.
Sällberg M; Zhang ZX; Chen M; Jin L; Birkett A; Peterson DL; Milich DR
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2721-8. PubMed ID: 8922465
[TBL] [Abstract][Full Text] [Related]
40. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
